CONNECT WITH US
Tech

Tech

Cannabis for Insomnia? The Verdict Is Shaky, Review Finds

Gizmodo - Tech logo

Published on

Add as a preferred source on Google
Cannabis for Insomnia? The Verdict Is Shaky, Review Finds

Many people struggle with their sleep, and there’s no shortage of treatments out there that can purportedly help us regain some dozing time. Unfortunately for the many people who reach for cannabis to fight insomnia, a comprehensive review published this week found little solid evidence that it helps.

In a new Cochrane Library review, scientists conducted a sweeping analysis of randomized clinical trials looking at medical-grade cannabis for insomnia. There was insufficient evidence supporting the idea that cannabis could reliably relieve insomnia, they concluded. Though it’s still possible the drug can be a useful sleep aid, better studies are needed to know for sure, the researchers say.

“I would not interpret these findings as proof that medical cannabis does not work. Rather, they show that the available research is too limited and uncertain to give patients and clinicians a clear answer,” lead author Lucia Varela, a neurologist and fellow at the University of Manitoba in Canada, told Gizmodo.

Cochrane is a well-respected organization that regularly publishes reviews from independent research teams analyzing the clinical trial literature on important health topics, insomnia included. Scientists with The Cochrane Associate Center at the Universidad Hospital Italiano de Buenos Aires in Argentina and the University of Manitoba in Canada led this particular review, which was published Monday.

Varela and her team looked at nine studies that collectively involved 537 people between the ages of 18 and 76 being treated for insomnia. Most people in these studies were treated for primary insomnia, meaning insomnia not linked to another health condition.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.